Alexandria Honored: A Legacy of Life Science Innovation Recognized with Prestigious Charles A. Sanders Award

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a pioneering urban office REIT, and its venture capital arm, Alexandria Venture Investments, have been collectively bestowed with the esteemed 2025 Charles A. Sanders Award by the Biotechnology Innovation Organization (BIO). This remarkable accolade, considered BIO’s highest honor, celebrates their profound and enduring impact on advancing human health through unparalleled contributions to the life science industry.

The Charles A.

Sanders Award recognizes individuals and organizations that have made pioneering and visionary contributions, driving transformative innovations within the global biotechnology landscape. Alexandria's receipt of this award underscores its nearly three-decade-long commitment to nurturing and accelerating scientific breakthroughs, fostering a vibrant entrepreneurial ecosystem that has consistently pushed the boundaries of medical research and development.

At the heart of Alexandria’s distinguished legacy lies a unique dual approach.

Alexandria Real Estate Equities has revolutionized the development of high-quality, purpose-built laboratory and office spaces, meticulously designed to meet the complex demands of leading life science companies, academic institutions, and government entities. These strategically located campuses, often clustered in key innovation hubs across North America, serve as critical infrastructure, enabling scientists and researchers to collaborate, innovate, and bring groundbreaking discoveries from bench to bedside.

Complementing this foundational real estate expertise, Alexandria Venture Investments has emerged as a crucial capital provider, deploying strategic investments into some of the most promising life science startups and early-stage companies.

This venture arm actively identifies and supports enterprises with significant potential to develop novel therapeutics, diagnostics, and medical technologies, effectively bridging the funding gap that can often hinder nascent scientific endeavors. Their investment strategy is deeply rooted in a strong emphasis on translational research, aiming to convert scientific discoveries into practical applications that directly improve patient outcomes.

The leadership driving this monumental success has been pivotal.

Joel Marcus, Executive Chairman and Founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments, remarked on the profound honor, stating, “We are deeply humbled and incredibly proud to receive the 2025 Charles A. Sanders Award from BIO. This recognition is a testament to the dedication of our entire Alexandria team and the groundbreaking work of the visionary scientists, entrepreneurs, and institutions we have been privileged to support.

For nearly 30 years, our mission has been to be a steadfast partner in advancing human health, and this award energizes our commitment to continue building a better future through life-changing innovation.”

Stephen A. Richardson, Co-CEO, and Peter M. Moglia, Co-CEO, further emphasized the company’s forward-looking vision.

Their joint leadership continues to expand Alexandria’s reach and impact, ensuring the company remains at the forefront of supporting biotech and pharmaceutical innovation. The integrated approach of providing best-in-class infrastructure alongside vital capital has created an unparalleled ecosystem that fuels discovery and accelerates the journey of life-saving therapies to market.

This prestigious award not only celebrates Alexandria's past achievements but also highlights its ongoing role as a cornerstone of the global life science community.

By continuously investing in cutting-edge facilities and breakthrough companies, Alexandria Real Estate Equities and Alexandria Venture Investments are not just building properties; they are building the future of healthcare, driving advancements that will benefit generations to come and solidifying their position as true catalysts for a healthier world.